Gene therapy prospects - Intranasal delivery of therapeutic genes

Advances in Clinical and Experimental Medicine

Volumn 21, Issue 4, 2012, Pages 525-534

  Podolska, Karolina ^a   Stachurska, Anna ^a,b   Hajdukiewicz, Karolina ^a,b   Małecki, Maciej ^a,b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Alpha 1 antitrypsin deficiency; Cystic fibrosis; Gene preparations; Gene therapy; Inhalation; Lung cancer

Indexed keywords

ADENOVIRUS VECTOR; DOXORUBICIN; DRUG CARRIER; GENE THERAPY AGENT; LENTIVIRUS VECTOR; LIPOFECTIN; PARVOVIRUS VECTOR; PLASMID DNA; PLASMID VECTOR; PROTEIN P53; RETROVIRUS VECTOR; SERINE PROTEINASE INHIBITOR; SMALL INTERFERING RNA; VIRUS GLYCOPROTEIN;

AEROSOL; ALPHA 1 ANTITRYPSIN DEFICIENCY; CYSTIC FIBROSIS; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; LUNG CANCER; NONHUMAN; REVIEW; VIRAL GENE DELIVERY SYSTEM;

ADENO-ASSOCIATED VIRUS;

EID: 84866387467     PISSN: 18995276     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Koshkina NV, Agoulnik IY, Melton SL, Densmore CL, Knight V: Biodistribution and pharmacokinetics of aerosol and intravenously administered DNA-polyethyleneimine complexes: optimization of pulmonary delivery and retention. Mol Ther 2003, 8, 249-254. (Pubitemid 37062835)
2. Sakagami M: In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 2006, 58, 1030-1060.
3. Davies LA, McLachlan G, Sumner-Jones SG, Ferguson D, Baker A, Tennant P, Gordon C, Vrettou C, Baker E, Zhu J, Alton EW, Collie DD, Porteous DJ, Hyde SC, Gill DR: Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes. Mol Ther 2008, 16, 1283-1290. (Pubitemid 351866060)
4. Jin H, Xu CX, Kim HW, Chung YS, Shin JY, Chang SH, Park SJ, Lee ES, Hwang SK, Kwon JT, Minai-Tehrani A, Woo M, Noh MS, Youn HJ, Kim DY, Yoon BI, Lee KH, Kim TH, Cho CS, Cho MH: Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-ras(LA1) mice. Cancer Gene Ther 2008, 15, 275-283. (Pubitemid 351508133)
5. Sinn PL, Burnight ER, Hickey MA, Blissard GW, McCray Jr PB: Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J Virol 2005, 79, 12818-12827. (Pubitemid 41433201)
6. Limberis MP, Wilson JM: Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc Natl Acad Sci USA 2006, 103, 12993-12998. (Pubitemid 44338905)
7. Brown BD, Sitia G, Annoni A, Hauben E, Sergi LS, Zingale A, Roncarolo MG, Guidotti LG, Naldini L: In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 2007, 109, 2797-2805. (Pubitemid 46482074)
8. Kobinger GP, Limberis MP, Somanathan S, Schumer G, Bell P, Wilson JM: Human immunodeficiency viral vector pseudotyped with the spike envelope of severe acute respiratory syndrome coronavirus transduces human airway epithelial cells and dendritic cells. Hum Gene Ther 2007, 18, 413-422. (Pubitemid 46850133)
9. Xenariou S, Griesenbach U, Liang HD, Zhu J, Farley R, Somerton L, Singh C, Jeffery PK, Ferrari S, Scheule RK, Cheng SH, Geddes DM, Blomley M, Alton EW: Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Ther 2007, 14, 768-774. (Pubitemid 46585658)
10. Damjanovic D, Zhang X, Mu J, Medina MF, Xing Z: Organ distribution of transgene expression following intranasal mucosal delivery of recombinant replication-defective adenovirus gene transfer vector. Gen Vaccines Ther 2008, 6, 5.
11. Sinn PL, Arias AC, Brogden KA, McCray Jr PB: Lentivirus vector can be readministered to nasal epithelia without blocking immune responses. J Virol 2008, 82, 10684-10692. (Pubitemid 352691165)
12. Limberis MP, Vandenberghe LH, Zhang L, Pickles RJ, Wilson JM: Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol Ther 2009, 17, 294-301.
13. Liu F, Shollenberger LM, Conwell CC, Yuan X, Huang L: Mechanism of naked DNA clearance after intravenous injection, J Gene Med 2007, 9, 613-619. (Pubitemid 47073994)
14. Hwang SK, Jin H, Kwon JT, Chang SH, Kim TH, Cho CS, Lee KH, Young MR, Colburn NH, Beck Jr GR, Yang HS, Cho MH: Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther 2007, 14, 1353-1361. (Pubitemid 47365621)
15. Hess DR: The mask for noninvasive ventilation: principles of design and effects on aerosol delivery. J Aerosol Med 2007, 20, S98-99.
16. Leung K, Louca E, Munson K, Dutzar B, Anklesaria P, Coates AL: Calculating expected lung deposition of aerosolized administration of AAV vector in human clinical studies. J Gene Med 2007, 9, 10-21. (Pubitemid 46210951)
17. Lynch J, Behan N, Birkinshaw C: Factors controlling particle size during nebulization of DNA-polycation complexes. J Aerosol Med 2007, 20, 257-268. (Pubitemid 47463182)
18. Carpenter M, Epperly MW, Agarwal A, Nie S, Hricisak L, Niu Y, Greenberger JS: Inhalation delivery of manganese superoxide dismutase-plasmid/liposomes protects the murine lung from irradiation damage. Gene Ther 2005, 12, 685-693. (Pubitemid 40561507)
19. Lentz YK, Anchordoquy TY, Lengsfeld CS: Rationale for the selection of an aerosol delivery system for gene delivery. J Aerosol Med 2006, 19, 372-384. (Pubitemid 44735393)
20. Griesenbach U, Alton EW: Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy. Adv Drug Deliv Rev 2009, 61, 128-139.
21. Zou Y, Tornos C, Qiu X, Lia M, Perez-Soler R: p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatment. Clin Cancer Res 2007, 13, 4900-4908. (Pubitemid 47294798)
22. Liqun Wang R, McLaughlin RT, Cossette T, Tang Q, Foust K, Campbell-Thompson M, Martino A, Cruz P, Loiler S, Mueller C, Flotte TR: Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of alpha-1-antitrypsin using invasive and noninvasive delivery. Mol Ther 2009, 17, 81-77.
23. Harvey BG, Hackett NR, Ely S, Crystal RG: Host responses and persistence of vector genome following intrabrachial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals. Mol Ther 2001, 3, 206-215. (Pubitemid 32509823)
24. Liu X, Luo M, Guo C, Yan Z, Wang Y, Engelhardt JF: Comparative biology of rAAV transduction in ferret, pig and human airway epithelia. Gene Ther 2007, 14, 1543-1548. (Pubitemid 47570714)
25. Schambach A, Baum C: Clinical application of lentiviral vectors - concepts and practice. Curr Gene Ther 2008, 8, 474-482.
26. Sinn PL, Shah AJ, Donovan MD, McCray Jr PB: Viscoelastic gel formulations enhance airway epithelial gene transfer with viral vectors. Am J Respir Cell Mol Biol 2005, 32, 404-410. (Pubitemid 40629325)
27. Hwang SK, Kwon JT, Park SJ, Chang SH, Lee ES, Chung YS, Beck Jr GR, Lee KH, Piao L, Park J, Cho MH: Lentivirus-mediated carboxyl-terminal modulator protein gene transfection via aerosol in lungs of K-ras null mice. Gene Ther 2007, 14, 1721-1730. (Pubitemid 350238449)
28. Bhattarai SR, Kim SY, Jang KY, Yi HK, Lee YH, Bhattarai N, Nam SY, Lee DY, Kim HY, Hwang PH: Amphiphilic triblock copolymer poly(p-dioxanone-co-L- lactide)-block-poly(ethylene glycol), enhancement of gene expression and inhibition of lung metastasis by aerosol delivery. Gene Ther 2007, 14, 476-483. (Pubitemid 46390920)
29. Freimuth P, Philipson L, Carson SD: The coxsackievirus and adenovirus receptor, Curr Top Microbiol Immunol 2008, 323, 67-87.
30. Huang X, Yang Y: Innate immune recognition of viruses and viral vectors. Hum Gene Ther 2009, 20, 293-301.
31. Price AR, Limberis MP, Wilson JM, Diamond SL: Pulmonary delivery of adenovirus vector formulated with dexamethasone-spermine facilitates homologous vector re-administration. Gene Ther 2007, 14, 1594-1604. (Pubitemid 350056231)
32. Lee D, Zhang W, Shirley SA, Kong X, Hellermann GR, Lockey RF, Mohapatra SS: Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharm Res 2007, 24, 157-167. (Pubitemid 44902580)
33. Gill DR, Pringle IA, Hyde SC: Progress and prospects: the design and production of plasmid vectors. Gene Ther 2009, 16, 165-171.
34. Hyde SC, Pringle IA, Abdullah S, Lawton AE, Davies LA, Varathalingam A, Nunez-Alonso G, Green AM, Bazzani RP, Summer-Jones SG, Chan M, Li H, Yew NS, Cheng SH, Boyd AC, Davies JC, Griesenbach U, Porteous DJ, Sheppard DN, Munkonge FM, Alton EW, Gill DR: CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat Biotechnol 2008, 26, 549-551. (Pubitemid 351668040)
35. Dames P, Laner A, Maucksch C, Aneja MK, Rudolph C: Targeting of the glucocorticoid hormone receptor with plasmid DNA comprising glucocorticoid response elements improves nonviral gene transfer efficiency in the lungs of mice. J Gene Med 2007, 9, 820-829. (Pubitemid 47386867)
36. Zabner J, Couture LA, Gregory RJ, Graham SM, Smith AE, Welsh MJ: Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993, 75, 207-216. (Pubitemid 23320285)
37. Copreni E, Penzo M, Carrabino S, Conese M: Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis. Gene Ther 2004, 11, S67-75. (Pubitemid 39359450)
38. Ban H, Inoue M, Griesenbach U, Munkonge F, Chan M, Iida A, Alton EW, Hasegawa M: Expression and maturation of Sendai virus vector-derived CFTR protein: functional and biochemical evidence using a GFP-CFTR fusion protein. Gene Ther 2007, 14, 1688-1694. (Pubitemid 350238445)
39. Wang SY, Yang M, Xu XP, Qiu GF, Ma J, Wang SJ, Huang XX, Xu HX: Intranasal delivery of T-bet modulates the profile of helper T cell immune responses in experimental asthma. J Invest Allergol Clin Immunol 2008, 18, 357-365.
40. Duan X, Jia SF, Koshkina N, Kleinerman ES: Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases. Cancer 2006, 106, 1382-1388. (Pubitemid 43363918)
41. Xu CX, Jere D, Jin H, Chang SH, Chung YS, Shin JY, Kim JE, Park SJ, Lee YH, Chae CH, Lee KH, Beck Jr GR, Cho CS, Cho MH: Poly(ester amine)-mediated, aerosol-delivered Aktl small interfering RNA suppresses lung tumorigenesis. Am J Respir Crit Care Med 2008, 178, 60-73. (Pubitemid 351919194)
42. Hwang SK, Lim HT, Minai-Tehrani A, Lee ES, Park J, Park SB, Beck Jr GR, Cho MH: Repeated aerosol delivery of carboxyl-terminal modulator protein suppresses tumor in the lungs of K-rasLA1 mice. Am J Respir Crit Care Med 2009, 179, 1131-1140.
43. Ferrari S, Griesenbach U, Iida A, Farley R, Wright AM, Zhu J, Munkonge FM, Smith SN, You J, Ban H, Inoue M, Chan M, Singh C, Verdon B, Argent BE, Wainwright B, Jeffery PK, Geddes DM, Porteous DJ, Hyde SC, Gray MA, Hasegawa M, Alton EW: Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther 2007, 14, 1371-1379. (Pubitemid 47423736)
44. Brigham KL, Lane KB, Meyrick B, Stecenko AA, Strack S, Cannon DR, Caudill M, Canonico AE: Transfection of nasal mucosa with a normal alphal-antitrypsin gene in alpha1-antitrypsin-deficient subjects: comparison with protein therapy. Hum Gene Ther 2000, 11, 1023-1032. (Pubitemid 30250119)
45. Cruz PE, Mueller C, Cossette TL, Golant A, Tang Q, Beattie SG, Brantly M, Campbell-Thomson M, Blomenkamp KS, Teckman JH, Flotte TR: In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNA. Lab Invest 2007, 87, 893-902. (Pubitemid 47267814)
46. Metz R, DiCola M, Kurihara T, Bailey A, Frank B, Roecklein B, Blaese M: Mode of action of RNA/DNA oligonucleotides: progress in the development of gene repair as a therapy for alpha(1)-antitrypsin deficiency. Chest 2002, 121, 91S-97S. (Pubitemid 34248377)
47. Howard KA, Rahbek UL, Liu X, Damgaard CK, Glud SZ, Andersen MQ, Hovgaard M,B, Schmitz A, Nyengaard J,R, Besenbacher F, Kjems J: RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system: Mol Ther 2006, 14, 476-484. (Pubitemid 44296092)
48. Durcan N, Murphy C, Cryan SA: Inhalable siRNA: potential as a therapeutic agent in the lungs. Mol Pharm 2008, 5, 559-566.
49. Fukazawa T, Maeda Y, Durbin ML, Nakai T, Matsuoka J, Tanaka H, Naomoto Y, Tanaka N: Pulmonary adenocarcinoma-targeted gene therapy by a cancer- and tissue-specific promoter system. Mol Cancer Ther 2007, 6, 244-252. (Pubitemid 46206688)
50. Cai KH, Tse LY, Leung C, Tam PK, Xu R, Sham MH: Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin. Clin Cancer Res 2008, 14, 939-949. (Pubitemid 351232942)